Prostatic metastasis from intrahepatic cholangiocarcinoma

Affiliations

¹ Department of Urology, University of Heidelberg, Heidelberg, Germany.
² Department of Pathology, University of Heidelberg, Heidelberg, Germany.
³ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
⁴ Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
⁵ Department of Urology, Diakonissenkrankenhaus Mannheim, Mannheim, Germany.
⁶ Department of Medical Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
⁷ Liver Cancer Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.

Case Reports

Georgi Tosev et al. Urol Case Rep. 2018.

. 2018 Jul 18:20:90-91.

doi: 10.1016/j.eucr.2018.07.015. eCollection 2018 Sep.

¹ Department of Urology, University of Heidelberg, Heidelberg, Germany.
² Department of Pathology, University of Heidelberg, Heidelberg, Germany.
³ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
⁴ Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
⁵ Department of Urology, Diakonissenkrankenhaus Mannheim, Mannheim, Germany.
⁶ Department of Medical Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
⁷ Liver Cancer Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.

No abstract available

Keywords: Hematuria; Intrahepatic cholangiocarcinoma; LUTS; Prostate metastasis; Transurethral resection; Tumor angiogenesis.

Figures

1. Zietman A.L., Bae K., Slater J.D. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol. 2010;28(7):1106–1111. - PMC - PubMed
1. Xu L.B., Liu C., Gao G.Q. Nerve growth factor-β expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma. World J Surg. 2010;34(5):1039–1045. - PubMed
1. Muders M.H., Zhang H., Wang E. Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1. Canc Res. 2009;69(15):6042–6048. - PMC - PubMed
1. Sugimachi K., Aishima S.I., Taguchi K.I. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol. 2001;35(1):74–79. - PubMed
1. Nikoleishvili D., Pertia A., Trsintsadze O. Expression of p27 (Kip1), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells. Int Urol Nephrol. 2008;40(4):953–959. - PubMed